[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583316":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":10,"responsibleParty":34,"collaborators":36,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":10,"eligibilityCriteria":46,"healthyVolunteers":43,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":10,"studyType":53,"phases":10,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":61,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":67,"leadSponsor":69,"locationsCount":10},{"fullName":5,"class":6},"China Academy of Chinese Medical Sciences","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Liuwei Dihuang Pills",null,"The intervention in this cohort consisted of the Six-flavoured Dihuang Pill and the rest of the conventional treatment.",[13],"Drug: Liuwei Dihuang pills",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DRUG","Liuwei Dihuang pills","Conventional treatment （Hormones, selective 5-hydroxytryptamine reuptake inhibitors, etc.）+ Liu Wei Di Huang Pills",[9],[21],{"name":22,"affiliation":23,"role":24},"Lianxin Wang","Institute of Basic Research in Clinical Medicine, China Academy of Chinese","PRINCIPAL_INVESTIGATOR",[26,30],{"name":22,"role":27,"phone":28,"phoneExt":10,"email":29},"CONTACT","86-13521781839","wlxing2022@163.com",{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},"Shichu Zhao","86-18513049612","18513049612@163.com",{"type":24,"investigatorFullName":22,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Principal Investigator",[37,39],{"name":38,"class":6},"Lanxi Hospital of Traditional Chinese Medicine",{"name":40,"class":6},"First Affiliated Hospital of Harbin Medical University","100583316","a-real-world-clinical-study-on-the-treatment-of-menopausal-syndrome-with-liuwei-dihuang-pills-100583316",false,"NCT06874738","A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills","Inclusion Criteria:\n\n1. Age: 45-55 years old\n2. Patients with menopausal syndrome using Liuwei Dihuang Pills\n3. Kidney Yin Deficiency Syndrome\n\nExclusion Criteria:\n\n1. Individuals allergic to any components of the drug or excipients;\n2. Individuals with other endocrine diseases;\n3. Individuals with organic lesions of the reproductive system;\n4. Individuals who have undergone bilateral oophorectomy, hysterectomy, or have ovarian dysfunction;\n5. Individuals with endometrial hyperplasia or unexplained vaginal bleeding;\n6. Individuals with malignant tumors, hematologic, or immune system diseases;\n7. Individuals with severe cardiovascular, cerebrovascular, liver, or kidney diseases (e.g., serum transaminase levels more than 1.5 times the upper limit of normal, serum creatinine above the upper limit of normal);\n8. Individuals with psychiatric disorders or dependence on alcohol or drugs;\n9. Individuals with mental illness or communication barriers;\n10. Individuals with other conditions that, in the investigator's judgment, may reduce the likelihood of enrollment or complicate the study process are not suitable for participation in this clinical research.","FEMALE","45 Years","55 Years",{"count":51,"type":52},1000,"ESTIMATED","OBSERVATIONAL","To evaluate the clinical efficacy of the real-world Liuwei Dihuang pills for the treatment of female menopausal syndromes, and to provide a basis for effective, safe and rational clinical use of the drug.",[56],"Menopausal Syndrome",[9,58,59,60],"The real world","Efficacy","Clinical study","NOT_YET_RECRUITING","2025-03-08",{"date":64,"type":65},"2025-03-13","ACTUAL",{"date":62,"type":52},{"date":68,"type":52},"2026-12-30",{"name":5,"class":6}]